Introducing Historical Vignettes in .
作者信息
Palevsky Harold I, Butrous Ghazwan, Elliott C Gregory
机构信息
Perelman School of Medicine of the University of Pennsylvania, Penn Presbyterian Medical Center Philadelphia Pennsylvania USA.
Cardiopulmonary Sciences University of Kent Canterbury UK.
出版信息
Pulm Circ. 2025 Feb 19;15(1):e70061. doi: 10.1002/pul2.70061. eCollection 2025 Jan.
Abstract
摘要
相似文献
1
Introducing Historical Vignettes in .引入……中的历史轶事
Pulm Circ. 2025 Feb 19;15(1):e70061. doi: 10.1002/pul2.70061. eCollection 2025 Jan.
2
Nitric oxide in the cardiovascular and pulmonary circulation--a brief review of literatures and historical landmarks.心血管和肺循环中的一氧化氮——文献综述及历史里程碑
Chin J Physiol. 2007 Apr 30;50(2):43-50.
3
Fact or fiction: exploring the use of real stories in place of vignettes in interviews with informal carers.事实还是虚构：探讨在对非正式护理人员的访谈中使用真实故事代替小插曲的情况。
Nurse Res. 2014 Mar;21(4):39-43. doi: 10.7748/nr2014.03.21.4.39.e1230.
4
Inhaled nitric oxide for pulmonary hypertension after heart transplantation.吸入一氧化氮治疗心脏移植后肺动脉高压
Transplantation. 2001 Aug 27;72(4):638-41. doi: 10.1097/00007890-200108270-00013.
5
Historical vignettes in heart failure.心力衰竭的历史轶事。
Congest Heart Fail. 2008 Jan-Feb;14(1):54. doi: 10.1111/j.1751-7133.2008.07774.x.
6
Persistent pulmonary hypertension of the newborn: Historical perspectives.新生儿持续性肺动脉高压：历史透视。
Semin Fetal Neonatal Med. 2022 Aug;27(4):101323. doi: 10.1016/j.siny.2022.101323. Epub 2022 Feb 14.
7
The pulmonary circulation in congenital heart disease. II. Pulmonary hypertension.先天性心脏病中的肺循环。II. 肺动脉高压。
Herz. 1978 Apr;3(2):138-42.
8
9
The definition of pulmonary hypertension: history, practical implications and current controversies.肺动脉高压的定义：历史、实际意义及当前争议
Breathe (Sheff). 2021 Sep;17(3):210076. doi: 10.1183/20734735.0076-2021.
10
Pulmonary vascular disease in Fontan circulation-is there a rationale for pulmonary vasodilator therapies?Fontan循环中的肺血管疾病——肺血管扩张剂治疗是否有理论依据？
Cardiovasc Diagn Ther. 2021 Aug;11(4):1111-1121. doi: 10.21037/cdt-20-431.
本文引用的文献
1
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.定义被报道可导致肺动脉高压的基因的临床有效性。
Genet Med. 2023 Nov;25(11):100925. doi: 10.1016/j.gim.2023.100925. Epub 2023 Jul 5.
2
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.索他洛尔治疗肺动脉高压的3期试验
N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6.
3
William Harvey and the Discovery of the Circulation of the Blood.威廉·哈维与血液循环的发现
Circ Res. 2019 Apr 26;124(9):1300-1302. doi: 10.1161/CIRCRESAHA.119.314977.
4
Macitentan and morbidity and mortality in pulmonary arterial hypertension.马西替坦治疗肺动脉高压的发病率和死亡率。
N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917.
5
Riociguat for the treatment of pulmonary arterial hypertension.利奥西呱特治疗肺动脉高压。
N Engl J Med. 2013 Jul 25;369(4):330-40. doi: 10.1056/NEJMoa1209655.
6
Tadalafil therapy for pulmonary arterial hypertension.他达拉非治疗肺动脉高压。
Circulation. 2009 Jun 9;119(22):2894-903. doi: 10.1161/CIRCULATIONAHA.108.839274. Epub 2009 May 26.
7
Sildenafil citrate therapy for pulmonary arterial hypertension.枸橼酸西地那非治疗肺动脉高压
N Engl J Med. 2005 Nov 17;353(20):2148-57. doi: 10.1056/NEJMoa050010.
8
Primary pulmonary hypertension. I. Clinical and hemodynamic study.原发性肺动脉高压。I. 临床与血流动力学研究。
Am J Med. 1951 Dec;11(6):686-705. doi: 10.1016/0002-9343(51)90020-4.
9
Pulmonary hypertension with special reference to the vasoconstrictive factor.肺动脉高压，特别涉及血管收缩因子
Br Heart J. 1958 Oct;20(4):557-70. doi: 10.1136/hrt.20.4.557.
10
Bosentan therapy for pulmonary arterial hypertension.波生坦治疗肺动脉高压
N Engl J Med. 2002 Mar 21;346(12):896-903. doi: 10.1056/NEJMoa012212.
Zotero 插件